Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427-kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the g...
Egile Nagusiak: | Nowak, K, Davies, K |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2004
|
Antzeko izenburuak
-
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
nork: Yingyin Liang, et al.
Argitaratua: (2015-05-01) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
nork: Guiraud, S, et al.
Argitaratua: (2019) -
Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
nork: Davies, K, et al.
Argitaratua: (2019) -
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
nork: Cedric Happi Mbakam, et al.
Argitaratua: (2022-03-01) -
Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
nork: Griffin, J, et al.
Argitaratua: (2002)